Geodon Related Clinical Trials
A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder [Completed]
Geodon in Weight Loss Study for Bipolar Disorders [Completed]
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions [Completed]
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions [Completed]
Geodon for the Treatment of Refractory Social Anxiety Disorder [Completed]
Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder [Completed]
Ziprasidone in Pediatric Bipolar Disorder [Completed]
Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression [Completed]
Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome [Completed]
Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State [Completed]
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders [Completed]
Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder [Terminated]
Geodon (Ziprasidone) for Posttraumatic Stress Disorder [Completed]
An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression [Completed]
Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder [Completed]
Treatment of Major Depressive Disorder (MDD) With Ziprasidone [Completed]
Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs [Completed]
Effectiveness of Ziprasidone for Patients With Schizophrenia [Completed]
Treatment of Schizophrenic Patients With Ziprasidone [Completed]
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome [Terminated]
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome [Terminated]
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone [Completed]
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects [Completed]
Ziprasidone in Children With Autism: A Pilot Study [Completed]
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics [Completed]
Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression [Completed]
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad) [Completed]
A Six-Week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression. [Completed]
Adjunctive Ziprasidone in the Treatment of Bipolar I Depression [Completed]
Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed) [Completed]
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule [Completed]
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade [Completed]
Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders [Completed]
A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation [Completed]
Ziprasidone And Olanzapine's Outcomes In Mania [Terminated]
A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs [Completed]
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) [Completed]
Ziprasidone in the Psychosis Prodrome [Completed]
Ziprasidone in Early Onset Schizophrenia Spectrum Disorders [Completed]
High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms [Completed]
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders. [Completed]
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study [Completed]
Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania [Recruiting]
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia [Completed]
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone [Completed]
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia [Terminated]
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196) [Withdrawn]
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study [Recruiting]
A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Completed]
A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study [Completed]
A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder [Terminated]
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia [Terminated]
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis [Completed]
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs [Completed]
Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) [Withdrawn]
Ziprasidone in the Treatment of Borderline Personality Disorder [Completed]
A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia [Terminated]
A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression [Completed]
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis [Completed]
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up [Completed]
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone [Completed]
Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac) [Completed]
Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder [Completed]
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder [Recruiting]
Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus [Completed]
Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study [Completed]
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients [Completed]
Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) [Completed]
Open-label Ziprasidone Study for Psychosis Treatment in Adolescents [Completed]
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes [Completed]
Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial [Completed]
Ziprasidone and Sertraline in PTSD [Terminated]
Safety And Efficacy Study Of Ziprasidone In Pediatric Psychotic Illness [Completed]
Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. [Completed]
Pfizer/IVGTT/Ziprasidone/Olanzapine [Completed]
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients [Terminated]
Ziprasidone vs Standard Therapy for Agitated Patients in the ED [Active, not recruiting]
Efficacy and Safety With Ziprasidone in First-episode Psychosis [Completed]
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia [Completed]
A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients [Completed]
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) [Completed]
Energy Homeostasis Under Treatment With Atypical Antipsychotics [Completed]
Mozart Relapse Study [Completed]
Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) [Completed]
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain [Not yet recruiting]
Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 [Completed]
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder [Completed]
Influence of Treatment With Olanzapine or Ziprasidone on Transcapillary Glucose Transport in Human Skeletal Muscle [Completed]
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting [Completed]
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome [Completed]
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients [Completed]
Glucose and Lipid Metabolism on Antipsychotic Medication [Completed]
IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) [Completed]
Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation [Completed]
Switching Medication to Treat Schizophrenia [Completed]
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole [Completed]
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics [Completed]
Antipsychotics and Gene Expression in Soft Tissues [Active, not recruiting]
|
